Live Breaking News & Updates on Leland Metheny

Stay updated with breaking news from Leland metheny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward

Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space. ....

United States , Leland Metheny , Oncology Program At Case Comprehensive Cancer Center , University Hospitals Cleveland Medical Center , Case Western Reserve University School Of Medicine , Case Western Reserve University School , Immune Oncology Program , Case Comprehensive Cancer Center , Hematologic Oncology , Glioblastoma Multiforme ,

Homing in on Currently Recruiting Clinical Trials With Practice Changing Implications in Lymphoma and Myeloma

Leland Metheny, MD, discusses ongoing clinical trials and their implications for the field of hematologic oncology. ....

United States , Wesley Center , Case Western Reserve University , Leland Metheny , University Hospitals Cleveland Medical Center , Case Western Reserve University School Of Medicine , Oncology Program At Case Comprehensive Cancer Center , Seidman Cancer Center , Uh Wesley Center , University Hospitals Seidman Cancer Center , Science Summit , Case Western Reserve University School , Immune Oncology Program , Case Comprehensive Cancer Center , Seidman Cancer , Hematologic Oncology ,

University Hospitals first in Ohio to treat patients with two FDA approved CAR T cancer therapies

University Hospitals first in Ohio to treat patients with two FDA approved CAR T cancer therapies
Latest immunotherapies target multiple myeloma and diffuse large B-cell lymphoma
News provided by
Share this article
Share this article
CLEVELAND, May 6, 2021 /PRNewswire/ Oncologists at University Hospitals (UH) have two new powerful tools in the fight against cancer following the announcement that Abecma & Breyanzi, from Bristol Myers Squibb (BMS), are currently being used to treat patients at UH Seidman Cancer Center.
Providing these latest CAR T-cell therapies to our patients is just another way UH Seidman Cancer Center is leading the way in immunotherapy, says Ted Teknos, MD, President and Chief Scientific Director of UH Seidman. Last fall, the Wesley Center for Immunotherapy at UH Seidman was named in honor of Kimberly and Joseph Wesley. The Wesley Family donated $10 million to support groundbreaking research to bring new, life-extending immunothe ....

Wesley Center , United States , Leland Metheny , Abecma Breyanzi , Ehsan Malek , Ted Teknos , Joseph Wesley , Bristol Myers Squibb , University Hospitals , Prnewswire Oncologists At University Hospitals , Uh Seidman Cancer Center , Cancer Center , Chief Scientific Director , Wesley Family , வெஸ்லி மையம் , ஒன்றுபட்டது மாநிலங்களில் , லேலண்ட் மீத்தேனி , ஜோசப் வெஸ்லி , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , பல்கலைக்கழகம் மருத்துவமனைகள் , இம் ஸைட்மந் புற்றுநோய் மையம் , புற்றுநோய் மையம் , தலைமை அறிவியல் இயக்குனர் , வெஸ்லி குடும்பம் ,